(Q73353972)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11141697%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

title

Long-acting octreotide LAR compared with lanreotide SR in the treatment of acromegaly (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11141697%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

author name string

P Kendall-Taylor

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11141697%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

M Miller

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11141697%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

J Gebbie

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11141697%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

S Turner

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11141697%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

M al-Maskari

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11141697%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

publication date

1 October 2000

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11141697%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11141697%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

volume

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11141697%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11141697%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

page(s)

61-65

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11141697%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1023/a:1009997506216

3 November 2019

exact match

0 references

cites work

Treatment of acromegaly with the long-acting somatostatin analog SMS 201-995

1 reference

12 December 2020

Current treatment guidelines for acromegaly

1 reference

12 December 2020

Sandostatin LAR in acromegalic patients: long-term treatment

1 reference

12 December 2020

Comparison of monthly intramuscular injections of Sandostatin LAR with multiple subcutaneous injections of octreotide in the treatment of acromegaly; effects on growth hormone and other markers of growth hormone secretion.

1 reference

12 December 2020

1 reference

12 December 2020

Long-term treatment of acromegaly with the slow-release somatostatin analogue lanreotide

1 reference

12 December 2020

A long-term dose-response study of somatostatin analogue (SMS 201-995, octreotide) in resistant acromegaly.

1 reference

12 December 2020

The therapeutic value of somatostatin and its analogues

1 reference

12 December 2020

Medical treatment of acromegaly with SMS 201-995, a somatostatin analog: a comparison with bromocriptine

1 reference

12 December 2020

Clinical review 75: Recent advances in pathogenesis, diagnosis, and management of acromegaly

1 reference

12 December 2020

Slow release lanreotide treatment in acromegalic patients previously normalized by octreotide

1 reference

12 December 2020

Three year follow-up of acromegalic patients treated with intramuscular slow-release lanreotide

1 reference

12 December 2020

Medical therapy with somatostatin analogues for acromegaly

1 reference

12 December 2020

Depot long-acting somatostatin analog (Sandostatin-LAR) is an effective treatment for acromegaly

1 reference

12 December 2020

Clinical results of long-term slow-release lanreotide treatment of acromegaly

1 reference

12 December 2020

Pharmacokinetics and efficacy of the long-acting somatostatin analogue somatuline in acromegaly

1 reference

12 December 2020

Carbohydrate tolerance and serum lipids in acromegaly before and during treatment with high dose octreotide.

1 reference

12 December 2020

Changes in glucose tolerance and development of gall stones during high dose treatment with octreotide for acromegaly

1 reference

12 December 2020

The effect of a new slow-release, long-acting somatostatin analogue, lanreotide, in acromegaly.

1 reference

12 December 2020

A comparison of lanreotide and octreotide LAR for treatment of acromegaly

1 reference

12 December 2020

Glucose tolerance during long term treatment with a somatostatin analogue.

1 reference

12 December 2020

Octreotide as primary therapy for acromegaly.

1 reference

12 December 2020

Sandostatin LAR: a promising therapeutic tool in the management of acromegalic patients

1 reference

12 December 2020

Safety and efficacy of long-term octreotide therapy of acromegaly: results of a multicenter trial in 103 patients--a clinical research center study.

1 reference

12 December 2020

Long-term treatment of 189 acromegalic patients with the somatostatin analog octreotide. Results of the International Multicenter Acromegaly Study Group

1 reference

12 December 2020